A study of a medicine for heavy bleeding after childbirth in India
Part of Women’s health & pregnancy clinical trials.
This study tests a medicine called eptacog alfa to see if it is safe for women in India who have severe bleeding after giving birth. It is for women who did not get better with standard treatments to help the uterus contract.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult woman aged 18 years or older.
- You gave birth after 27 weeks of pregnancy.
- You are diagnosed with severe bleeding after childbirth that did not stop with standard medicines.
- You do not have a history of blood clots or bleeding disorders.
- You do not have certain severe pregnancy complications like HELLP syndrome or pre-eclampsia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a specific combination of three medicines during a planned c-section is better than one medicine alone for preventing postpartum hemorrhage (heavy bleeding after birth).
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.
This study looks at how safe and effective Octocog alfa (a Factor VIII medicine) is for treating sudden bleeds in adults with severe hemophilia A in India. It is for people who already have experience with Factor VIII products and are not on regular preventive treatment.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This trial tests whether taking an oral medication called tranexamic acid can reduce heavy bleeding after childbirth in women planning a vaginal delivery. It may help you have a safer birth with less blood loss.
Hear when a new Severe Postpartum Haemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.